Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Rahul Bhambri, Jack Mardekian, Larry Z Liu, Edward Schweizer & Elodie Ramos. (2015) A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine. International Journal of General Medicine 8, pages 27-36.
Read now
Read now
Hartmut Göbel. (2010) Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis. Expert Review of Neurotherapeutics 10:4, pages 499-506.
Read now
Read now
Michel Dib. (2008) Optimizing prophylactic treatment of migraine: Subtypes and patient matching. Therapeutics and Clinical Risk Management 4:5, pages 1061-1078.
Read now
Read now
Miguel JA Láinez. (2006) Rizatriptan in the treatment of migraine. Neuropsychiatric Disease and Treatment 2:3, pages 247-259.
Read now
Read now
Eleanor M Perfetto, Prasun Subedi, Paul J Healey Sr & Kathleen A Weis. (2005) Economic and patient-reported outcomes of oral triptans in the treatment of migraine. Expert Review of Pharmacoeconomics & Outcomes Research 5:5, pages 553-566.
Read now
Read now
Hans-Christoph Diener. (2005) Eletriptan in migraine. Expert Review of Neurotherapeutics 5:1, pages 43-53.
Read now
Read now
Articles from other publishers (15)
Deborah Dowell, Kathleen R. Ragan, Christopher M. Jones, Grant T. Baldwin & Roger Chou. (2022)
CDC Clinical Practice Guideline for Prescribing Opioids for Pain
—
United States, 2022
. MMWR. Recommendations and Reports 71:3, pages 1-95.
Crossref
Crossref
Doug Coyle, Karen M. Lee, Muhammad Mamdani, Kelley-Anne Sabarre & Kylie Tingley. (2015) Reimbursement-Based Economics - What Is It and How Can We Use It to Inform Drug Policy Reform?. Headache: The Journal of Head and Face Pain 55, pages 236-247.
Crossref
Crossref
Vishvas Garg, Xian Shen, Yan Cheng, James J Nawarskas & Dennis W Raisch. (2016) Use of Number Needed to Treat in Cost-Effectiveness Analyses. Annals of Pharmacotherapy 47:3, pages 380-387.
Crossref
Crossref
Piia K. PeuraJanne A. MartikainenTimo T. PurmonenJuha H. O. Turunen. (2011) Sponsorship-Related Outcome Selection Bias in Published Economic Studies of Triptans. Medical Decision Making 32:2, pages 237-245.
Crossref
Crossref
SYM Mérelle, EGM Couturier, J van Bokhorst, JJV Busschbach & J Passchier. (2009) Large-Scale Screening and Subsequent Effects of Migraine Treatment on the Work Floor in the Netherlands. Cephalalgia 29:6, pages 606-615.
Crossref
Crossref
Elisabeth Hazard, Julie Munakata, Marcelo E. Bigal, Marcia F.T. Rupnow & Richard B. Lipton. (2009) The Burden of Migraine in the United States: Current and Emerging Perspectives on Disease Management and Economic Analysis. Value in Health 12:1, pages 55-64.
Crossref
Crossref
C. Daniel Mullins, Prasun R. Subedi, Paul J. Healey & Robert J. Sanchez. (2012) Economic Analysis of Triptan Therapy for Acute Migraine: A Medicaid Perspective. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27:8, pages 1092-1101.
Crossref
Crossref
J Ramsberg & M Henriksson. (2016) The Cost-Effectiveness of Oral Triptan Therapy in Sweden. Cephalalgia 27:1, pages 54-62.
Crossref
Crossref
H. Göbel, A. Heinze & K. Heinze-Kuhn. (2006) Vorbeugung und Akutbehandlung der MigräneProphylactic measures and acute treatment of migraine. Der Schmerz 20:6, pages 541-556.
Crossref
Crossref
Leslie Kelman & Randal L Von Seggern. (2006) Using Patient-Centered Endpoints to Determine the Cost-Effectiveness of Triptans for Acute Migraine Therapy. American Journal of Therapeutics 13:5, pages 411-417.
Crossref
Crossref
H-C Diener, P Montagna, G Gács, P Lyczak, G Schumann, B Zöller, LJMM Mulder, J Siegel & K Edson. (2016) Efficacy and Tolerability of Diclofenac Potassium Sachets in Migraine. Cephalalgia 26:5, pages 537-547.
Crossref
Crossref
M-S Yoon, Z. Katsarava, B. Liedert, K. J. Krobot, H. C. Diener & V. Limmroth. (2006) Company reference estimates for productivity loss due to migraine and productivity gains using rizatriptan 10 mg in Germany. International Journal of Clinical Practice 60:3, pages 295-299.
Crossref
Crossref
Paul L McCormack & Gillian M Keating. (2006) Eletriptan. Drugs 66:8, pages 1129-1149.
Crossref
Crossref
Liza Takiya, Lisa C. Piccininni & Veena Kamath. (2012) Safety and Efficacy of Eletriptan in the Treatment of Acute Migraine. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26:1, pages 115-128.
Crossref
Crossref
N. Poolsup, V. Leelasangaluk, J. Jittangtrong, C. Rithlamlert, N. Ratanapantamanee & M. Khanthong. (2005) Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials. Journal of Clinical Pharmacy and Therapeutics 30:6, pages 521-532.
Crossref
Crossref